全文获取类型
收费全文 | 3971篇 |
免费 | 202篇 |
国内免费 | 25篇 |
专业分类
耳鼻咽喉 | 21篇 |
儿科学 | 97篇 |
妇产科学 | 93篇 |
基础医学 | 435篇 |
口腔科学 | 74篇 |
临床医学 | 268篇 |
内科学 | 928篇 |
皮肤病学 | 152篇 |
神经病学 | 328篇 |
特种医学 | 109篇 |
外科学 | 780篇 |
综合类 | 17篇 |
预防医学 | 378篇 |
眼科学 | 43篇 |
药学 | 209篇 |
中国医学 | 25篇 |
肿瘤学 | 241篇 |
出版年
2023年 | 24篇 |
2022年 | 56篇 |
2021年 | 92篇 |
2020年 | 56篇 |
2019年 | 103篇 |
2018年 | 119篇 |
2017年 | 89篇 |
2016年 | 90篇 |
2015年 | 100篇 |
2014年 | 138篇 |
2013年 | 172篇 |
2012年 | 304篇 |
2011年 | 317篇 |
2010年 | 163篇 |
2009年 | 165篇 |
2008年 | 216篇 |
2007年 | 285篇 |
2006年 | 256篇 |
2005年 | 245篇 |
2004年 | 233篇 |
2003年 | 202篇 |
2002年 | 176篇 |
2001年 | 73篇 |
2000年 | 63篇 |
1999年 | 51篇 |
1998年 | 27篇 |
1997年 | 21篇 |
1996年 | 25篇 |
1995年 | 13篇 |
1994年 | 18篇 |
1993年 | 14篇 |
1992年 | 28篇 |
1991年 | 25篇 |
1990年 | 23篇 |
1989年 | 26篇 |
1988年 | 14篇 |
1987年 | 10篇 |
1986年 | 9篇 |
1985年 | 9篇 |
1984年 | 10篇 |
1983年 | 10篇 |
1982年 | 8篇 |
1980年 | 9篇 |
1979年 | 8篇 |
1978年 | 6篇 |
1977年 | 13篇 |
1976年 | 11篇 |
1975年 | 7篇 |
1974年 | 12篇 |
1970年 | 10篇 |
排序方式: 共有4198条查询结果,搜索用时 15 毫秒
41.
Chutimon Khemtong Antonio Tessitore Salvador J. Jaime Giuliana Gobbi Jrgen Jensen Ai-Lun Yang Chia-Hua Kuo Giancarlo Condello 《Nutrients》2022,14(20)
BCAAs supplementation has been widely used for post-exercise recovery. However, no evidence is currently available to answer the question of whether BCAAs supplementation can attenuate muscle damage and ameliorate recovery after a bout of change of direction (COD) sprinting, which is an exercise motion frequently used during team sport actions. This study aimed to assess the effect of BCAAs supplementation on muscle damage markers, subjective muscle soreness, neuromuscular performance, and the vascular health of collegiate basketball players during a 72 h recovery period after a standardized COD protocol. Participants orally received either BCAAs (0.17 g/kg BCAAs + 0.17 g/kg glucose) or placebo (0.34 g/kg glucose) supplementation before and immediately after a COD exercise protocol in a randomized, crossover, double-blind, and placebo-controlled manner. Creatine kinase increased immediately after exercise and peaked at 24 h, muscle soreness remained elevated until 72 h, whilst arterial stiffness decreased after exercise for both supplemented conditions. A negligibly lower level of interleukin-6 was found in the BCAAs supplemented condition. In conclusion, the results of this study do not support the benefits of BCAAs supplementation on mitigating muscle damage and soreness, neuromuscular performance, and arterial stiffness after COD for basketball players. 相似文献
42.
Eckhard Schlemm Mrit Jensen Amy Kuceyeski Keith Jamison Thies Ingwersen Carola Mayer Alina Knigsberg Florent Boutitie Martin Ebinger Matthias Endres Jochen B. Fiebach Jens Fiehler Ivana Galinovic Robin Lemmens Keith W. Muir Norbert Nighoghossian Salvador Pedraza Josep Puig Claus Z. Simonsen Vincent Thijs Anke Wouters Christian Gerloff Gtz Thomalla Bastian Cheng 《Human brain mapping》2022,43(16):5053
The symptoms of acute ischemic stroke can be attributed to disruption of the brain network architecture. Systemic thrombolysis is an effective treatment that preserves structural connectivity in the first days after the event. Its effect on the evolution of global network organisation is, however, not well understood. We present a secondary analysis of 269 patients from the randomized WAKE‐UP trial, comparing 127 imaging‐selected patients treated with alteplase with 142 controls who received placebo. We used indirect network mapping to quantify the impact of ischemic lesions on structural brain network organisation in terms of both global parameters of segregation and integration, and local disruption of individual connections. Network damage was estimated before randomization and again 22 to 36 h after administration of either alteplase or placebo. Evolution of structural network organisation was characterised by a loss in integration and gain in segregation, and this trajectory was attenuated by the administration of alteplase. Preserved brain network organization was associated with excellent functional outcome. Furthermore, the protective effect of alteplase was spatio‐topologically nonuniform, concentrating on a subnetwork of high centrality supported in the salvageable white matter surrounding the ischemic cores. This interplay between the location of the lesion, the pathophysiology of the ischemic penumbra, and the spatial embedding of the brain network explains the observed potential of thrombolysis to attenuate topological network damage early after stroke. Our findings might, in the future, lead to new brain network‐informed imaging biomarkers and improved prognostication in ischemic stroke. 相似文献
43.
Abdel‐Hadi Al‐Ja'fari Roser Vila Blanca Freixa Joan Costa Salvador Cañigueral 《Phytotherapy research : PTR》2013,27(6):911-915
The antifungal activity of hexane, dichloromethane, methanol and aqueous extracts from the rhizome and root of Ferula hermonis was assayed in vitro by the agar disk diffusion method against a panel of human opportunistic and pathogenic fungi. Among them, the hexane and dichloromethane extracts showed the highest activity particularly against the dermatophytes Microsporum gypseum and Tricophyton mentagrophytes as well as the yeast Candida lactis‐condensi. Activity‐guided fractionation of both extracts using an agar overlay bioautographic method led to the isolation of two antifungal compounds which were identified as the daucane aryl esters jaeschkeanadiol p‐hydroxybenzoate (ferutinin) and jaeschkeanadiol benzoate (teferidin). Determination of minimal inhibitory concentration (MIC) and minimal fungicidal concentration (MFC) values of both compounds evidenced a stronger antifungal activity for ferutinin than for teferidin. Particularly, T. mentagrophytes was the most sensitive strain with MIC and MFC values ranging from 8 to 256 µg/mL. Copyright © 2012 John Wiley & Sons, Ltd. 相似文献
44.
The pistachio is regarded as a relevant source of biologically active components that, compared to other nuts, possess a healthier nutritional profile with low-fat content composed mainly of monounsaturated fatty acids, a high source of vegetable protein and dietary fibre, remarkable content of minerals, especially potassium, and an excellent source of vitamins, such as vitamins C and E. A rich composition in terms of phytochemicals, such as tocopherols, carotenoids, and, importantly, phenolic compounds, makes pistachio a powerful food to explore its involvement in the prevention of prevalent pathologies. Although pistachio has been less explored than other nuts (walnut, almonds, hazelnut, etc.), many studies provide evidence of its beneficial effects on CVD risk factors beyond the lipid-lowering effect. The present review gathers recent data regarding the most beneficial effects of pistachio on lipid and glucose homeostasis, endothelial function, oxidative stress, and inflammation that essentially convey a protective/preventive effect on the onset of pathological conditions, such as obesity, type 2 diabetes, CVD, and cancer. Likewise, the influence of pistachio consumption on gut microbiota is reviewed with promising results. However, population nut consumption does not meet current intake recommendations due to the extended belief that they are fattening products, their high cost, or teething problems, among the most critical barriers, which would be solved with more research and information. 相似文献
45.
46.
Anna V. Tinker Alon D. Altman Marcus Q. Bernardini Prafull Ghatage Lilian T. Gien Diane Provencher Shannon Salvador Sarah Doucette Amit M. Oza 《Current oncology (Toronto, Ont.)》2022,29(6):4354
The majority of patients with advanced, high-grade epithelial-tubo ovarian cancer (EOC) respond well to initial treatment with platinum-based chemotherapy; however, up to 80% of patients will experience a recurrence. Poly(ADP-ribose) Polymerase (PARP) inhibitors have been established as a standard of care maintenance therapy to prolong remission and prevent relapse following a response to first-line platinum-chemotherapy. Olaparib and niraparib are the PARP inhibitors currently approved for use in the first-line maintenance setting in Canada. Selection of maintenance therapy requires consideration of patient and tumour factors, presence of germline and somatic mutations, expected drug toxicity profile, and treatment access. This paper discusses the current clinical evidence for first-line PARP inhibitor maintenance therapy in patients with advanced, high-grade EOC and presents consensus statements and a treatment algorithm to aid Canadian oncologists on the selection and use of PARP inhibitors within the Canadian EOC treatment landscape. 相似文献
47.
Salvador Moncada 《European Journal of Pain》2016,20(10):1549-1550
48.
49.